Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer.
about
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinomaMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerAnatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future ImplicationsThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesDynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenationQuantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions.Imaging brain oxygenation with MRI using blood oxygenation approaches: methods, validation, and clinical applications.Hypoxia as a biomarker for radioresistant cancer stem cells.High-field small animal magnetic resonance oncology studies.Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor.Quantitative phase-filtered wavelength-modulated differential photoacoustic radar tumor hypoxia imaging toward early cancer detection.Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T.Evaluation of the R2* value in invasive ductal carcinoma with respect to hypoxic-related prognostic factors using iterative decomposition of water and fat with echo asymmetry and least-squares emission (IDEAL).PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.Correlation between BOLD-MRI and HIF expression level in renal carcinoma.Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3TCharacterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) modelAssessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapyCharacterizing gradient echo signal decays in gynecologic cancers at 3T using a Gaussian augmentation of the monoexponential (GAME) modelFractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model.Blood Oxygenation Level-dependent Magnetic Resonance Imaging of Breast Cancer: Correlation with Carbonic Anhydrase IX and Vascular Endothelial Growth Factor.Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials.Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers.Functional MRI and CT biomarkers in oncology.Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor Ktrans and ΔR2* peak are significantly associated with lymph node metastasis.Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniquesIncorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer.Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation responseTasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.BOLD-MRI of breast invasive ductal carcinoma: correlation of R2* value and the expression of HIF-1α.Prospective evaluation of term neonate brain damage following preceding hypoxic sentinel events using enhanced T₂* weighted angiography (eSWAN).Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study.Multiparametric High-Resolution MRI as a Tool for Mapping of Hypoxic Level in Tumors
P2860
Q26745449-C4B4154C-4206-4B25-81F5-2F9E659CB4AFQ26766638-7EA428A5-A0CA-457B-98D2-5004574B5DECQ26996400-CF4B1A40-5DAF-41F8-B105-6AAC922A4D90Q27025579-D70A175B-0044-467A-9B7A-A6CD2CB1F1C8Q30377914-99296066-3199-42EE-8FB3-45D852E03F11Q34106364-914FBD87-CD8A-4237-B62B-DFBA397C0412Q34363900-747B1D68-99C7-4DC1-B6A4-8CA011111B2EQ34420732-A5795D94-387F-4916-8CCB-5D9322A40742Q35312455-CF717122-ADB3-481E-A71E-1E41C3D0F9C9Q35700926-032A9B34-8811-4ED6-A7C5-DF54B930B7D9Q36167333-27C39024-7B9A-4F00-9C44-44CD23E06DD2Q36243580-D7447A6A-ABF3-40FF-A4D8-B500C679C260Q36344176-185CD832-6959-47EE-9620-3E56095FC36EQ36357752-2ED83FE3-3C8A-440A-9345-0A0EC69BB98AQ36375656-186C350B-D243-40F8-A403-0A85E08DA173Q37025426-BEE771C3-BF25-4BEC-B344-32B8ADCAC435Q37118580-897DC92A-F6C7-4A9F-AE46-7AAFAA64ED70Q37175628-4CD972F4-AAFC-43C5-9C9A-F550C3A36ACFQ37247987-42BE1333-868D-4CF0-B111-65163D13DFFCQ37310865-BADFE080-EBD9-4BD2-BC9E-C22F075C877BQ37450656-BF3F05A0-9F95-40B7-A160-A862B27A8AD0Q37572430-C39C8375-1F6F-44F2-BA66-3C4414432B43Q37711455-BFBB065B-C861-4C5A-A0CF-0C53F1FE7EA1Q38057714-5713411E-6A1A-4538-ACCF-8DEEA9A5291CQ38132855-40954131-AF18-40E3-8355-CC62F21A9593Q38314429-D4B7ADA2-BEB6-44F3-8119-157682751181Q38685910-045D23C3-2AC0-42FE-83BE-F3EB546C4E59Q38768460-3A8E0132-CEDD-4B97-84C3-FE4FE4FE2461Q39046269-80AC889A-0A76-4A34-A9BE-E706BD6BEDD4Q40445567-B4AFB13C-5C28-490D-8E2F-3EF7EF3CE864Q41664708-BCAD1535-F82F-4CB5-BFC0-71F7131B8B49Q41784125-C7FB5C7D-86F6-44D2-99AC-D93CB99BA965Q41836745-C7D0E768-CA3A-45C5-818D-FA48FB6BCAAEQ44539026-F9477B34-B79E-48C2-9DE9-53348F5B4A71Q45917535-873E30FF-2FA9-4D85-A445-37901761139CQ52668175-67F14E21-DF84-494C-BA1A-D159F5E83545Q57182090-7C8B9E68-E9C6-4D73-8EB2-E5A239837DC1
P2860
Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparing oxygen-sensitive MRI ...... y in men with prostate cancer.
@en
Comparing oxygen-sensitive MRI
@nl
type
label
Comparing oxygen-sensitive MRI ...... y in men with prostate cancer.
@en
Comparing oxygen-sensitive MRI
@nl
prefLabel
Comparing oxygen-sensitive MRI ...... y in men with prostate cancer.
@en
Comparing oxygen-sensitive MRI
@nl
P2093
P2860
P1476
Comparing oxygen-sensitive MRI ...... y in men with prostate cancer.
@en
P2093
Cynthia Ménard
Masoom A Haider
Supriya Chopra
Warren D Foltz
P2860
P304
P356
10.1080/09553000903043059
P577
2009-09-01T00:00:00Z